Platelet, Neutrophil and Lymphocyte Quantitative Abnormalities in Patients with Heart Failure: A Retrospective Study

References

• Naik N, Narula J. Heart failure in low-income and middle-income countries: failing REPORT card grades. Lancet Global Health. 2020;8(3):e318. doi:10.1016/S2214-109X(20)30028-0
   Web of Science ®Google Scholar
• Bragazzi NL, Zhong W, Shu J, et al. Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017. Eur J Prev Cardiol. 2021;28(15):1682–1690. doi:10.1093/eurjpc/zwaa147
   PubMed Web of Science ®Google Scholar
• Groenewegen A, Rutten FH, Mosterd A, Hoes AW. Epidemiology of heart failure. Eur J Heart Fail. 2020;22(8):1342–1356. doi:10.1002/ejhf.1858
   PubMed Web of Science ®Google Scholar
• Angaw DA, Ali R, Tadele A, Shumet S. The prevalence of cardiovascular disease in Ethiopia: a systematic review and meta-analysis of institutional and community-based studies. BMC Cardiovasc Disord. 2021;21(1):1–9. doi:10.1186/s12872-020-01828-z
   PubMed Web of Science ®Google Scholar
• Zhu Z, Zhou S. Leukocyte count and the risk of adverse outcomes in patients with HFpEF. BMC Cardiovasc Disord. 2021;21(1):1–9. doi:10.1186/s12872-021-02142-y
   Web of Science ®Google Scholar
• Kalogeropoulos A, Georgiopoulou V, Psaty BM, et al. Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study. J Am Coll Cardiol. 2010;55(19):2129–2137. doi:10.1016/j.jacc.2009.12.045
   PubMed Web of Science ®Google Scholar
• Engström G, Melander O, Hedblad B. Leukocyte count and incidence of hospitalizations due to heart failure. Circ Heart Fail. 2009;2(3):217–222. doi:10.1161/CIRCHEARTFAILURE.108.827071
   PubMed Web of Science ®Google Scholar
• Ahmad A, Alharbi MN, Aldhabaan OA, et al. Prevalence and risk factors of leukocytosis among heart failure patients. Int J Med Dev Countries. 2019;3(5):468–473. doi:10.24911/IJMDC.51-1547423021
   Google Scholar
• Jan AF, Habib S, Naseeb K, Khatri MA, Zaman KS. High total leukocyte count and heart failure after myocardial infarction. Pakistan Heart J. 2011;44:1–2.
   Google Scholar
• Madjid M, Fatemi O. Components of the complete blood count as risk predictors for coronary heart disease: in-depth review and update. Texas Heart Institute J. 2013;40(1):17.
   PubMed Web of Science ®Google Scholar
• Núñez J, Miñana G, Bodí V, et al. Low lymphocyte count and cardiovascular diseases. Curr Med Chem. 2011;18(21):3226–3233. doi:10.2174/092986711796391633
   PubMed Web of Science ®Google Scholar
• Bian C, Wu Y, Shi Y, et al. Predictive value of the relative lymphocyte count in coronary heart disease. Heart Vessels. 2010;25(6):469–473. doi:10.1007/s00380-010-0010-7
   PubMed Web of Science ®Google Scholar
• Delcea C, Buzea C, Daha I, et al. P751 Low platelets in heart failure: small cells, important impact on all-cause long-term mortality. Eur Heart J. 2019;40(Supplement_1):ehz747. doi:10.1093/eurheartj/ehz747.0353
   Google Scholar
• Lassale C, Curtis A, Abete I, van der Schouw Y, Verschuren W, Lu Y. Elements of the complete blood count associated with cardiovascular disease incidence: findings from the EPIC-NL cohort study. Sci Rep. 2018;8(1):1–11. doi:10.1038/s41598-018-21661-x
   PubMedGoogle Scholar
• Polat N, Yildiz A, Bilik MZ, et al. The importance of hematologic indices in the risk stratification of patients with acute decompensated systolic heart failure. Turk Kardiyol Dern Ars. 2015;43(2):157–165. doi:10.5543/tkda.2015.76281
   PubMedGoogle Scholar
• Bao K, Huang H, Huang G, et al. Platelet-to-hemoglobin ratio as a valuable predictor of long-term all-cause mortality in coronary artery disease patients with congestive heart failure. BMC Cardiovasc Disord. 2021;21(1):1–9. doi:10.1186/s12872-021-02423-6
   Web of Science ®Google Scholar
• Kassa E, Enawgaw B, Gelaw A, Gelaw B. Effect of anti-tuberculosis drugs on hematological profiles of tuberculosis patients attending at University of Gondar Hospital, Northwest Ethiopia. BMC Hematol. 2016;16(1):1–11. doi:10.1186/s12878-015-0037-1
   Google Scholar
• Erkurt MA, Kaya E, Berber I, Koroglu M, Kuku I. Thrombocytopenia in adults. J Hematol. 2012;1(2–3):44–53.
   Google Scholar
• Tefferi A, Hanson CA, Inwards DJ. How to Interpret and Pursue an Abnormal Complete Blood Cell Count in Adults. Elsevier; 2005.
   Google Scholar
• Seaquist ER, Anderson J, Childs B, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care. 2013;36(5):1384–1395. doi:10.2337/dc12-2480
   PubMed Web of Science ®Google Scholar
• Bisetegn H, Feleke DG, Debash H, Erkihun Y, Ebrahim H. Hematological and Biochemical changes in Schistosoma mansoni infected patients at Haik Primary Hospital, North-East Ethiopia: a comparative cross-sectional study. PLoS Negl Trop Dis. 2022;16(8):e0010728. doi:10.1371/journal.pntd.0010728
   Web of Science ®Google Scholar
• Glezeva N, Voon V, Watson C, et al. Exaggerated inflammation and monocytosis associate with diastolic dysfunction in heart failure with preserved ejection fraction: evidence of M2 macrophage activation in disease pathogenesis. J Card Fail. 2015;21(2):167–177. doi:10.1016/j.cardfail.2014.11.004
   Web of Science ®Google Scholar
• Glezeva N, Gilmer JF, Watson CJ, Ledwidge M. A central role for monocyte–platelet interactions in heart failure. J Cardiovasc Pharmacol Ther. 2016;21(3):245–261. doi:10.1177/1074248415609436
   Web of Science ®Google Scholar
• Davì G, Patrono C. Platelet activation and atherothrombosis. N Eng J Med. 2007;357(24):2482–2494. doi:10.1056/NEJMra071014
   PubMed Web of Science ®Google Scholar
• Balta S, Ozturk C. The platelet-lymphocyte ratio: a simple, inexpensive and rapid prognostic marker for cardiovascular events. Platelets. 2015;26(7):680–681. doi:10.3109/09537104.2014.979340
   PubMed Web of Science ®Google Scholar
• Uçar FM, Açar B, Gul M, Özeke Ö, Aydogdu S. The association between platelet/lymphocyte ratio and coronary artery disease severity in asymptomatic low ejection fraction patients. Korean Circ J. 2016;46(6):821–826. doi:10.4070/kcj.2016.46.6.821
   PubMed Web of Science ®Google Scholar
• Bajaj NS, Kalra R, Gupta K, et al. Leucocyte count predicts cardiovascular risk in heart failure with preserved ejection fraction: insights from TOPCAT Americas. ESC Heart Failure. 2020;7(4):1676–1687. doi:10.1002/ehf2.12724
   Web of Science ®Google Scholar
• Wheeler JG, Mussolino ME, Gillum RF, Danesh J. Associations between differential leucocyte count and incident coronary heart disease: 1764 incident cases from seven prospective studies of 30 374 individuals. Eur Heart J. 2004;25(15):1287–1292. doi:10.1016/j.ehj.2004.05.002
   PubMed Web of Science ®Google Scholar
• Kain V, Halade GV. Role of neutrophils in ischemic heart failure. Pharmacol Ther. 2020;205:107424. doi:10.1016/j.pharmthera.2019.107424
   Web of Science ®Google Scholar
• Arruda-Olson AM, Reeder GS, Bell MR, Weston SA, Roger VL. Neutrophilia predicts death and heart failure after myocardial infarction: a community-based study. Circ Cardiovasc Qual Outcomes. 2009;2(6):656–662. doi:10.1161/CIRCOUTCOMES.108.831024
   PubMed Web of Science ®Google Scholar
• Russell CJ, Exley AR, Ritchie AJ. Widespread coronary inflammation in unstable angina. N Eng J Med. 2003;348(19):1931. doi:10.1056/NEJM200305083481919
   Web of Science ®Google Scholar
• Dinerman JL, Mehta JL, Saldeen TG, et al. Increased neutrophil elastase release in unstable angina pectoris and acute myocardial infarction. J Am Coll Cardiol. 1990;15(7):1559–1563. doi:10.1016/0735-1097(90)92826-N
   PubMed Web of Science ®Google Scholar
• Biasucci LM, D’Onofrio G, Liuzzo G, et al. Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia. J Am Coll Cardiol. 1996;27(3):611–616. doi:10.1016/0735-1097(95)00524-2
   PubMed Web of Science ®Google Scholar
• Naruko T, Ueda M, Haze K, et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation. 2002;106(23):2894–2900. doi:10.1161/01.CIR.0000042674.89762.20
   PubMed Web of Science ®Google Scholar
• Tracchi I, Ghigliotti G, Mura M, et al. Increased neutrophil lifespan in patients with congestive heart failure. Eur J Heart Fail. 2009;11(4):378–385. doi:10.1093/eurjhf/hfp031
   PubMed Web of Science ®Google Scholar
• Narducci ML, Grasselli A, Biasucci LM, et al. High telomerase activity in neutrophils from unstable coronary plaques. J Am Coll Cardiol. 2007;50(25):2369–2374. doi:10.1016/j.jacc.2007.08.048
   Web of Science ®Google Scholar
• Yan X, Anzai A, Katsumata Y, et al. Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction. J Mol Cell Cardiol. 2013;62:24–35. doi:10.1016/j.yjmcc.2013.04.023
   PubMed Web of Science ®Google Scholar
• Frangogiannis NG. Regulation of the inflammatory response in cardiac repair. Circ Res. 2012;110(1):159–173. doi:10.1161/CIRCRESAHA.111.243162
   PubMed Web of Science ®Google Scholar
• Rudiger A, Burckhardt OA, Harpes P, Müller SA, Follath F. The relative lymphocyte count on hospital admission is a risk factor for long-term mortality in patients with acute heart failure. Am J Emerg Med. 2006;24(4):451–454. doi:10.1016/j.ajem.2005.10.010
   PubMed Web of Science ®Google Scholar
• Vaduganathan M, Ambrosy AP, Greene SJ, et al. Predictive value of low relative lymphocyte count in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial. Circ Heart Fail. 2012;5(6):750–758. doi:10.1161/CIRCHEARTFAILURE.112.970525
   PubMed Web of Science ®Google Scholar
• Ommen SR, Hodge DO, Rodeheffer RJ, McGregor CG, Thomson SP, Gibbons RJ. Predictive power of the relative lymphocyte concentration in patients with advanced heart failure. Circulation. 1998;97(1):19–22. doi:10.1161/01.CIR.97.1.19
   PubMed Web of Science ®Google Scholar
• Chao DT, Korsmeyer SJ. BCL-2 family: regulators of cell death. Annu Rev Immunol. 1998;1:16.
   Google Scholar
• Strasser A, Harris AW, Huang D, Krammer PH, Cory S. Bcl‐2 and Fas/APO‐1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 1995;14(24):6136–6147. doi:10.1002/j.1460-2075.1995.tb00304.x
   PubMed Web of Science ®Google Scholar
• Mojadidi MK, Galeas JN, Goodman-Meza D, et al. Thrombocytopaenia as a prognostic indicator in heart failure with reduced ejection fraction. Heart Lung Circ. 2016;25(6):568–575. doi:10.1016/j.hlc.2015.11.010
   PubMed Web of Science ®Google Scholar
• Aynalem M, Adane T, Getawa S. Magnitude of Coagulation Abnormalities and Associated Factors Among Patients with Heart Diseases at the University of Gondar Comprehensive Specialized Hospital. Vasc Health Risk Manag. 2022;18:617. doi:10.2147/VHRM.S371912
   PubMed Web of Science ®Google Scholar
• Gregg D, Goldschmidt-Clermont PJ. Platelets and cardiovascular disease. Circulation. 2003;108(13):e88–e90. doi:10.1161/01.CIR.0000086897.15588.4B
   Web of Science ®Google Scholar
• Klinger MH, Jelkmann W. Role of blood platelets in infection and inflammation. J Interferon Cytokine Res. 2002;22(9):913–922. doi:10.1089/10799900260286623
   PubMed Web of Science ®Google Scholar
• Chung I, Lip GY. Platelets and heart failure. Eur Heart J. 2006;27(22):2623–2631. doi:10.1093/eurheartj/ehl305
   PubMed Web of Science ®Google Scholar